Nan Fung Group Holdings »

Eliem Therapeutics shares owned by Nan Fung Group Holdings

Quarter-by-quarter ownership of Eliem Therapeutics (ELYM) shares owned by Nan Fung Group Holdings from 13F filings

Historical chart of Nan Fung Group Holdings investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by Nan Fung Group Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by Nan Fung Group Holdings

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.4M 464k 5.09

More positions owned by Nan Fung Group Holdings

Illumina (ILMN)
Harmony Biosciences Hldgs In (HRMY)
Geron Corporation (GERN)
Merus N V (MRUS)
Zai Lab Adr (ZLAB)
Longboard Pharmaceuticals In (LBPH)
Oculis Holding Ordinary Shares (OCS)
Beigene Sponsored Adr (BGNE)
Incyte Corporation (INCY)
Xenon Pharmaceuticals (XENE)
Exscientia Ads (EXAI)
Mirum Pharmaceuticals (MIRM)
Tourmaline Bio (TRML)
D Fluidigm Corp Del (LAB)
Soleno Therapeutics (SLNO)

View all positions for Nan Fung Group Holdings

Top funds holding Eliem Therapeutics

RA Capital Management
Deep Track Capital
Samsara BioCapital
Henderson Group
Boxer Capital
BlackRock
Affinity Asset Advisors
Driehaus Capital Management
Geode Capital Management
Nan Fung Group Holdings
BlackRock
Vanguard Group
Northern Trust
Dr. Jeffrey R. Jay, M.D.
Monashee Investment Management

View all funds holding Eliem Therapeutics